Invivyd, Inc. (IVVD) vs Lyell Immunopharma, Inc. (LYEL)
- Invivyd, Inc. IVVD 0.67 +9.84%
- Lyell Immunopharma, Inc. LYEL 8.19 +2.50%
Invivyd, Inc. and Lyell Immunopharma, Inc. are both Biotechnology companies. Invivyd, Inc. and Lyell Immunopharma, Inc. are of similar size ($195.8M and $190.4M). Invivyd, Inc. grew revenue faster over the last twelve months: 26.3% against −55.0%. Invivyd, Inc. has the higher net margin (−183.9% vs −920,285.2%) and the higher return on invested capital (−334.9% vs −539.5%). Across the 16 metrics below, Invivyd, Inc. leads on 11 and Lyell Immunopharma, Inc. on 5.
Valuation
Profitability
| Metric | IVVD | LYEL | Biotechnology median |
|---|---|---|---|
| Gross margin | 92.23% | 100.00% | 65.16% |
| Operating margin | (192.81%) | (949,981.48%) | 0.00% |
| Net margin | (183.90%) | (920,285.19%) | 0.00% |
| Free cash flow margin | (187.88%) | (647,681.48%) | 0.00% |
| Return on equity | (95.89%) | (93.28%) | (56.36%) |
| Return on assets | (69.69%) | (71.34%) | (48.04%) |
| Return on invested capital | (334.92%) | (539.53%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack